India’s rapidly growing medical technology sector is set to receive its first dedicated investment fund of ₹1,000 crore, aimed at accelerating innovation, strengthening domestic manufacturing, and supporting high-growth medtech companies across the country.The proposed fund, MedArtha Capital, recently received regulatory approval and will focus on